PNS Shifa Hospital
Karachi, Sindh, 46000, Pakistan
NCT Number: NCT06065956
Comparing hemodynamic changes with morphine versus esmolol as an adjuvant agent during induction of Anaesthesia
Looking for future studies?
Notify Me25 year–55 year
All sexes
Interventional
Phase 1 / Phase 2
Karachi, Sindh, 46000, Pakistan
Comparing hemodynamic profile of patients during induction of General Anesthesia with intravenous morphine as an adjuvant drug versus Intravenous esmolol as an adjuvant agent,My aim is to study which drug has superior hemodynamic profile in terms of hemodynamic stability of patient requiring General Anesthesia.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Morphine group(an opioid), participants were given intravenous morphine(an opioid) at induction of General Anaesthesia before laryngoscopy and intubation.
The other group,Esmolol group(cardioselective beta blocker), participants were given intravenous esmolol(cardioselective beta blocker) during induction of General Anesthesia before laryngoscopy and intubation.
Other names: Intravenous esmolol
Time frame: 06 months
Change in blood pressure between baseline value and post Intubation value will be measured in millimeter of mercury (mmHg).
Time frame: 06 months
Change in pulse rate between baseline value and post intubation value will be measured per minute.
Pakistan Navy Station Shifa Hospital
Other
Comparison of Hemodynamic Changes With Morphine Versus Esmolol as an Adjuvant Agent During Induction of Anaesthesia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06327399
Dexmedetomidine, Intubation Complication
Giza, Giza Governorate, Egypt
View Trial DetailsNCT04079387
Critical Illness, Critically Ill
Montpellier, Languedoc-Roussillon, France
View Trial DetailsNCT06727513
Airway Trauma, Intubation Complication
Beirut, Lebanon
View Trial DetailsNCT07125495
Infection, Infections
Istanbul, Turkey (Türkiye)
View Trial Details